Sulfhemoglobinemia

Sulfhemoglobinemia
Synonyms
Pronounce	N/A
Specialty	N/A
Symptoms	Cyanosis, fatigue, headache, dizziness
Complications
Onset
Duration
Types
Causes	Sulfhemoglobin formation due to exposure to sulfur compounds
Risks
Diagnosis	Blood test
Differential diagnosis	Methemoglobinemia, cyanosis
Prevention	Avoidance of sulfur-containing drugs
Treatment	Discontinuation of the causative agent
Medication
Prognosis	Generally good with removal of the cause
Frequency	Rare
Deaths

Sulfhemoglobinemia

Sulfhemoglobinemia is a rare condition characterized by the presence of sulfhemoglobin (SulfHb) in the blood. Sulfhemoglobin is an abnormal form of hemoglobin, the oxygen-carrying protein found in red blood cells, that has been irreversibly modified by the binding of a sulfur atom.

Etiology

• The primary cause of sulfhemoglobinemia is the exposure to drugs or substances that contain or can metabolize into sulfur. Such substances include:
• Sulfonamides
• Phenacetin
• Metoclopramide
• Nitrates
• Some antibiotics
• In rare cases, the condition can be idiopathic (without a known cause).

Clinical Manifestations

Patients with sulfhemoglobinemia often exhibit a characteristic cyanotic (blue-green) discoloration of the skin and mucous membranes, as sulfhemoglobin cannot effectively bind and carry oxygen. This can lead to hypoxia, although most patients do not usually have significant symptoms unless the SulfHb levels are quite high.

Diagnosis

Diagnosis of sulfhemoglobinemia is made by performing a blood test known as a methemoglobinemia and sulfhemoglobinemia blood test. This test differentiates between methemoglobin, a similarly modified form of hemoglobin, and sulfhemoglobin.

Treatment

There is currently no known treatment for sulfhemoglobinemia. The body cannot naturally break down sulfhemoglobin, so the condition is typically managed by identifying and removing the source of sulfur exposure. Over time, the body will naturally replace the modified red blood cells with normal ones.

Prognosis

In most cases, sulfhemoglobinemia is not life-threatening. However, severe or prolonged hypoxia can potentially result in organ damage, so individuals with this condition should be closely monitored.

See Also

• Methemoglobinemia
• Cyanosis
• Hypoxia (medical)

References

• Mayo Clinic. (2023). Sulfhemoglobinemia. Retrieved from https://www.mayoclinic.org/sulfhemoglobinemia
• National Institutes of Health. (2023). Sulfhemoglobinemia. Retrieved from https://www.ncbi.nlm.nih.gov/books/NBK470/
• American Society of Hematology. (2023). Sulfhemoglobinemia. Retrieved from http://www.hematology.org/Patients/Blood-Disorders/Blood-Basics/5220.aspx

This article is a medical stub. You can help WikiMD by expanding it!
Most recent articles Ongoing trials	Wikipedia